Clark Tedford of LumiThera joins the Fall Edition on 7th-9th November 2016
October 31, 2016 – Monaco Growth Forums by Andreea Porcelli announced the invitation of LumiThera, a developmental stage medical device Company creating a multi-wavelength “photoceuticals” approach for chronic ocular diseases and disorders, to present at the forum’s Fall Edition on 7th-9th November 2016. This pre-eminent investment event is an exclusive, invitation-only series of conferences featuring emerging growth companies seeking capital and/or greater exposure. Clark Tedford, LumiThera’s Co-Founder, will be presenting the mission of LumiThera to nearly 200 attendees representing institutional fund managers, private asset managers, high net worth individuals, and industry-related sponsors and foundations – all also selected by invitation-only.
Clark E. Tedford, Ph.D. is one of the founders of LumiThera and has served as President and CEO since the formation of the Company in 2013. Previously Dr. Tedford was Vice President and Chief Science Officer at PhotoThera, a leading LED/laser company from 2010-2012. Prior to PhotoThera, Dr. Tedford was at Omeros from 2003-2010 as Vice President, Pharmaceutical Research. Prior to Omeros, Dr. Tedford was President of Solentix, Inc. During Dr. Tedford’s 25 years in the pharmaceutical and medical device industry, he has held several scientific and executive management positions from 1993-2003 including Executive Vice President of Research and Development for Gliatech, Inc. Prior to that Dr. Tedford was at Schering-Plough Research Institute as a Principal Scientist. Dr. Tedford received his Ph.D. in pharmacology from the University of Iowa and completed his post-doctoral work in the Department of Pharmacology at the Loyola University Medical School.
LumiThera, Inc. is a developmental-stage medical device company focused on treating patients affected by dry AMD. The Company’s expertise is in the application of PBM, using non-invasive light emitting diodes (LED) and laser treatments for acute and chronic ocular diseases and disorders. The Company is developing an ophthalmic LED office-based instrument to be used in multiple ocular conditions or disorders as non-invasive medical treatments.
About Monaco Growth Forums by Andreea Porcelli Ltd.
Monaco Growth Forums is an exclusive, invitation-only conference highlighting growth companies seeking capital and/or greater exposure. Based on more than 20 years’ experience as an international Investment Banker finding investors for small cap companies on a world scale, MGF Founder and President Andrea Porcelli and her team select, by invitation-only, companies seeking international investor exposure to present and then socialize over three days with institutional fund managers, private asset managers, high net worth individuals, industry-related sponsors and foundations – all selected on an exclusive basis.